Studies heart conditions in adults with bronchiectasis flare-ups
Observes how heart problems affect bronchiectasis severity and quality of life in adults.
Key facts
- Who runs it
- Assiut University
- Where
- Asyut, EgyptSee the site
- Trial code
- Registry title
- Study of Bronchiectasis and Associated Cardiovascular Comorbidities
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 25 Mar 2023
- Expected to end
- 2 Feb 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Echocardiography
- Record updated
- 3 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 80 with bronchiectasis whose only other health problems are heart or blood vessel conditions. It studies how these conditions affect disease severity and quality of life.
- Age
- 18 to 80 years
- Sex
- Men and women can both join.
- Disease stage
- Bronchiectasis (not cystic fibrosis), during an acute flare-up (exacerbation).
Main reasons for not taking part
- People who refuse to take part
- People with any other illness or organ failure that may affect the results
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Any Patients with Bronchiectasis had no comorbidities other than cardiovascular comorbidities during the study period
Who cannot take part
- Any other comorbidity or end-organ failure may affect the study's result
- Any Patients who refuse to participate in the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in Egypt
- Assiut unviresty - Faculty of MedicineAsyut, EgyptContact: Ahmad Shaddad, LecturerTaking people
About the trial
What the trial wants to find out
Effect of cardiovascular comorbidities on disease severity and quality of life in Patients with acute exacerbation of non-cystic fibrosis bronchiectasis
The 2 groups in the trial
- Patient with bronchiectasis and cardiovascular comorbidities
Patients with Bronchiectasis had no comorbidities other than cardiovascular comorbidities during the study period.
Treatment: Echocardiography
- Patients with bronchiectasis and without cardiovascular comorbidities
Patients with Bronchiectasis had no comorbidities.
Treatment: Echocardiography
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Cardiovascular Comorbidities on Disease Severity and Quality of Life in Patients With Acute Exacerbation of Non-cystic Fibrosis Bronchiectasis
- Plain-language title
- Studies heart conditions in adults with bronchiectasis flare-upsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05783869, who can take part
- Record updated
- 3 November 2026